Rewind Therapeutics

📍 Heverlee, Belgium🗓 Founded 2017👥 19 employees💰 Last funded May 2020
Biotechnology Research🌐 rewindtherapeutics.com
Website LinkedIn
Rewind Therapeutics is developing first-in-class remyelinating therapies for myelin-related diseases and aims to bring them into fast-track clinical development. Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition and movement, among others. The causes of damage may be genetic, a result of infectious or autoimmune disease or from exposure to toxic agents or other forms of brain injury. There is no cure for demyelinating diseases. The Company was founded by KU Leuven’s Centre for Drug Design and Discovery (CD3) and Axxam S.p.A. (Milano, Italy), a leading provider of integrated discovery services for the Life Sciences. Rewind Therapeutics works in close collaboration with both organisations and a world-class academic network to advance its discovery and development activities. Rewind Therapeutics is backed by life science investors Boehringer Ingelheim Venture Fund, M Ventures and the Flemish investment company PMV, together with CD3 and KU Leuven Gemma Frisius Fonds.
4
Total investors
3
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Belgium
2
Netherlands
2
Investor activity2018–2020 · investors recorded per year
2018320201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Rewind Therapeutics?
Rewind Therapeutics has 4 investors on record on gritt.io, including 3 early-stage backers, 1 mid-stage.
When did Rewind Therapeutics last raise funding?
The most recent investment in Rewind Therapeutics recorded on gritt.io was in May 2020.
When was Rewind Therapeutics founded?
Rewind Therapeutics was founded in 2017.
What industry is Rewind Therapeutics in?
Rewind Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Rewind Therapeutics based?
Rewind Therapeutics is headquartered in Heverlee, Belgium.